Cargando…

Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3

PURPOSE: In our previous study, we found that AKR1C3 was a radioresistance gene in KY170R cells. Downregulating the expression of AKR1C3 could enhance the radiosensitivity of esophageal carcinoma cells. In this study, we investigated whether methyl jasmonate (MeJ), an inhibitor of Aldo-keto reductas...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoying, Hong, Xin, Gao, Xianshu, Gu, Xiaobin, Xiong, Wei, Zhao, Jing, Yu, Hongliang, Cui, Ming, Xie, Mu, Bai, Yun, Sun, Shaoqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124458/
https://www.ncbi.nlm.nih.gov/pubmed/30214307
http://dx.doi.org/10.2147/CMAR.S166942
_version_ 1783353030504087552
author Li, Xiaoying
Hong, Xin
Gao, Xianshu
Gu, Xiaobin
Xiong, Wei
Zhao, Jing
Yu, Hongliang
Cui, Ming
Xie, Mu
Bai, Yun
Sun, Shaoqian
author_facet Li, Xiaoying
Hong, Xin
Gao, Xianshu
Gu, Xiaobin
Xiong, Wei
Zhao, Jing
Yu, Hongliang
Cui, Ming
Xie, Mu
Bai, Yun
Sun, Shaoqian
author_sort Li, Xiaoying
collection PubMed
description PURPOSE: In our previous study, we found that AKR1C3 was a radioresistance gene in KY170R cells. Downregulating the expression of AKR1C3 could enhance the radiosensitivity of esophageal carcinoma cells. In this study, we investigated whether methyl jasmonate (MeJ), an inhibitor of Aldo-keto reductase family1 member C3 (AKR1C3), could overcome radiation resistance in AKR1C3 highly expressed cells. PATIENTS AND METHODS: We used clone formation assays to detect radiosensitivity effects. Flow cytometry assays were used to detect reactive oxygen species (ROS) accumulation and apoptosis. Enzyme linked immunosorbent assays (ELISAs) were used to detect the concentrations of prostaglandin F2 (PGF2) and prostaglandin D2 (PGD2) in the cells after incubation with MeJ. Western blotting was used to detect AKR1C3 and peroxisome proliferator-activated receptor gamma (PPARγ) expression. RESULTS: We found that AKR1C3 was highly expressed in radioresistant esophageal carcinoma cells. MeJ inhibited the expression of AKR1C3 and enhanced the radiation sensitivity of esophageal carcinoma cells expressing high levels of AKR1C3 (P<0.05). MeJ could inhibit the 11-ketoprostaglandin reductase activity of AKR1C3 in a dose-dependent manner in KY170R cells. Incubation of KY170R cells with 200 µmol/L of MeJ for 24 h reduced the expression of PGF2 by roughly 30% (P<0.05). The PPAR pathway inhibitor GW9662 prevented the radiation sensitivity enhancement imparted by MeJ. After adding GW9662, there were no significant differences between the radiation sensitivities of MeJ-treated and -untreated KY170R cells (P>0.05). The radiation sensitivity effect of MeJ also depended upon the generation of ROS in KY170R cells; 48 h after irradiation, ROS levels in the MeJ group was twofold higher than in the untreated KY170R cells (P<0.05). The ROS scavenger, N-acetyl cysteine, could reverse the radiosensitivity effects of MeJ (P>0.05). CONCLUSION: Our results indicate that MeJ can increase the radiation sensitivity of AKR1C3-overexpressing KY170R cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 and increasing cellular ROS levels.
format Online
Article
Text
id pubmed-6124458
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61244582018-09-13 Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 Li, Xiaoying Hong, Xin Gao, Xianshu Gu, Xiaobin Xiong, Wei Zhao, Jing Yu, Hongliang Cui, Ming Xie, Mu Bai, Yun Sun, Shaoqian Cancer Manag Res Original Research PURPOSE: In our previous study, we found that AKR1C3 was a radioresistance gene in KY170R cells. Downregulating the expression of AKR1C3 could enhance the radiosensitivity of esophageal carcinoma cells. In this study, we investigated whether methyl jasmonate (MeJ), an inhibitor of Aldo-keto reductase family1 member C3 (AKR1C3), could overcome radiation resistance in AKR1C3 highly expressed cells. PATIENTS AND METHODS: We used clone formation assays to detect radiosensitivity effects. Flow cytometry assays were used to detect reactive oxygen species (ROS) accumulation and apoptosis. Enzyme linked immunosorbent assays (ELISAs) were used to detect the concentrations of prostaglandin F2 (PGF2) and prostaglandin D2 (PGD2) in the cells after incubation with MeJ. Western blotting was used to detect AKR1C3 and peroxisome proliferator-activated receptor gamma (PPARγ) expression. RESULTS: We found that AKR1C3 was highly expressed in radioresistant esophageal carcinoma cells. MeJ inhibited the expression of AKR1C3 and enhanced the radiation sensitivity of esophageal carcinoma cells expressing high levels of AKR1C3 (P<0.05). MeJ could inhibit the 11-ketoprostaglandin reductase activity of AKR1C3 in a dose-dependent manner in KY170R cells. Incubation of KY170R cells with 200 µmol/L of MeJ for 24 h reduced the expression of PGF2 by roughly 30% (P<0.05). The PPAR pathway inhibitor GW9662 prevented the radiation sensitivity enhancement imparted by MeJ. After adding GW9662, there were no significant differences between the radiation sensitivities of MeJ-treated and -untreated KY170R cells (P>0.05). The radiation sensitivity effect of MeJ also depended upon the generation of ROS in KY170R cells; 48 h after irradiation, ROS levels in the MeJ group was twofold higher than in the untreated KY170R cells (P<0.05). The ROS scavenger, N-acetyl cysteine, could reverse the radiosensitivity effects of MeJ (P>0.05). CONCLUSION: Our results indicate that MeJ can increase the radiation sensitivity of AKR1C3-overexpressing KY170R cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3 and increasing cellular ROS levels. Dove Medical Press 2018-08-31 /pmc/articles/PMC6124458/ /pubmed/30214307 http://dx.doi.org/10.2147/CMAR.S166942 Text en © 2018 Li et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Li, Xiaoying
Hong, Xin
Gao, Xianshu
Gu, Xiaobin
Xiong, Wei
Zhao, Jing
Yu, Hongliang
Cui, Ming
Xie, Mu
Bai, Yun
Sun, Shaoqian
Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
title Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
title_full Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
title_fullStr Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
title_full_unstemmed Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
title_short Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of AKR1C3
title_sort methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of akr1c3
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124458/
https://www.ncbi.nlm.nih.gov/pubmed/30214307
http://dx.doi.org/10.2147/CMAR.S166942
work_keys_str_mv AT lixiaoying methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT hongxin methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT gaoxianshu methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT guxiaobin methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT xiongwei methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT zhaojing methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT yuhongliang methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT cuiming methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT xiemu methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT baiyun methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3
AT sunshaoqian methyljasmonateenhancestheradiationsensitivityofesophagealcarcinomacellsbyinhibitingthe11ketoprostaglandinreductaseactivityofakr1c3